Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2023 | Apr. 30, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q/A | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Mar. 31, 2023 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2023 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 001-40969 | |
Entity Registrant Name | ENTRADA THERAPEUTICS, INC. | |
Entity Central Index Key | 0001689375 | |
Entity Tax Identification Number | 81-3983399 | |
Entity Incorporation, State or Country Code | DE | |
Entity Address, Address Line One | One Design Center Place | |
Entity Address, Address Line Two | Suite 17-500 | |
Entity Address, City or Town | Boston | |
Entity Address, State or Province | MA | |
Entity Address, Postal Zip Code | 02210 | |
City Area Code | 857 | |
Local Phone Number | 520-9158 | |
Title of 12(b) Security | Common Stock, par value $0.0001 per share | |
Trading Symbol | TRDA | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Elected Not To Use the Extended Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 33,197,018 |